Allosteric modulation and accelerated resensitization of human P2X3 receptors by cibacron blue

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1135-1142

  Alexander, Karen ^a   Niforatos, Wende ^a   Bianchi, Bruce ^a   Burgard, Edward C ^a   Lynch, Kevin J ^a   Kowaluk, Elizabeth A ^a   Jarvis, Michael F ^a   Van Biesen, Tim ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHRAQUINONE DERIVATIVE; CALCIUM CHANNEL; CALCIUM ION; CIBACRON BLUE F3GA; COMPLEMENTARY DNA; ION CHANNEL; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SULFONIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; MEMBRANE CURRENT; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELL LINE; CELL MEMBRANE; ELECTROPHYSIOLOGY; HUMANS; KINETICS; OOCYTES; PROTEIN SYNTHESIS INHIBITORS; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; TRIAZINES; XENOPUS LAEVIS;

EID: 0032731865     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, Park HS, Yu H, Metzger R, Kowaluk E, Jarvis MF and van Biesen T (1999) Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 376:127-138.
2. Burgard EC, Niforatos W, van Biesen T, Lynch KJ, Touma E, Metzger RE, Kowaluk EA and Jarvis MF (1999) P2X receptor-mediated ionic currents in dorsal root ganglion neurons. J Neurophysiol 82:1590-1598.
3. Cook SP, Rodland KD and McCleskey EW (1998) A memory for extracellular Ca2+ by speeding recovery of P2X receptors from desensitization. J Neurosci 18:9238-9244.
4. 2 purinoceptors. J Gen Physiol 113:695-719.
5. Garcia-Guzman M, Stuhmer W and Soto F (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. Brain Res Mol Brain Res 47:59-66.
6. Hashimoto M and Kokubun S (1995) Contribution of P2-purinoceptors to neurogenic contraction of rat urinary bladder smooth muscle. Br J Pharmacol 115:636-640.
7. Kim M, Yoo OJ and Choe S (1997) Molecular assembly of the extracellular domain of P2X2, and ATP-gated ion channel. Biochem Biophys Res Commun 240:618-622.
8. Lê KT, Babinski K and Séguéla P (1998) Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 18:7152-7159.
9. Lewis C, Neidhart S, Holy C, North RA, Buell G and Surprenant A (1995) Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature (Lond) 377:432-435.
10. Li C, Peoples RW and Weight FF (1996a) Acid pH augments excitatory action of ATP on a dissociated mammalian sensory neuron, Neuroreport 7:2151-2154.
11. Li C, Peoples RW and Weight FF (1996b) Proton potentiation of ATP-gated ion channel responses to ATP and Zn2+ in rat nodose ganglion neurons. J Neurophysiol 78:3048-3058.
12. Manzini S, Hoyle CH and Burnstock G (1986) An electrophysiological analysis of the effect of reactive blue 2, a putative P2-purinoceptor antagonist, on inhibitory junction potentials of rat caecum. Eur J Pharmacol 127:197-204.
13. Michel AD, Grahames CB and Humphrey PPA (1996) Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmiedeberg's Arch Pharmacol 354:562-671.
14. Miller KJ, Michel AD, Chessell IP and Humphrey PPA (1998) Cibacron blue allosterically modulates the rat P2X4 receptor. Neuropharmacology 87:1579-1586.
15. Nakazawa K, Inoue K, Fujimori K and Takanaka A (1991) Effects of ATP antagonists on purinoceptor-operated inward currents in rat phaeochromocytoma cells. Pflugers Arch 418:214-219.
16. Nicke A, Baumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E and Schmalzing G (1998) P2X1 and P2X3 receptors form stable trimers: A novel structural motif of ligand-gated ion channels EMBO J 17:3016-3028.
17. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacological Rev 50:413-492.
18. Rice WR and Singleton FM (1989) Reactive blue 2 selectively inhibits P2y-purinoceptor-stimulated surfactant phospholipid secretion from rat isolated alveolar type II cells. Br J Pharmacol 97:158-162.
19. Robichon R, Randall PK and Leslie SW (1997) A partial agonist model used in the allosteric modulation of the NMDA receptor. Eur J Pharmacol 328:255-263.
20. Sigel E and Buhr A (1997) The benzodiazepine binding site of GABAA receptors. Trends Pharmacol Sci 18:425-429.
21. Soltoff SP, McMillian MK and Talamo BR (1989) Coomassie brilliant blue G is a more potent antagonist of P2 purinergic responses than reactive blue 2 (cibacron blue 3GA) in rat parotid acinar cells. Biochem Biophys Res Commun 165:1279-1285.
22. Stoop R, Surprenant A and North RA (1997) Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. J Neurophysiol 78:1837-1840.
23. Stout JG and Kirley TL (1995) Inhibition of purified chicken gizzard smooth muscle ecto-ATPAse by P2 purinoceptor antagonists. Biochem Mol Biol Int 36:927-934.
24. Surprenant A (1996) Functional properties of native and cloned P2X receptors. Ciba Found Symp 198:208-219.
25. Torres GE, Haines WR, Egan TM and Voigt MM (1998) Co-expression of P2X1 and P2X6 receptor subunits reveals a novel ATP-gated ion channel. Mol Pharmacol 54:989-993.
26. Ziganshin AU, Ziganshina LE, King BF, Pintor J and Burnstock G (1996) Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ectonucleotidases in folliculated oocytes of Xenopus laevis. Biochem Pharmacol 51: 897-901.
27. Ziganshina LE, Ziganshin AU, Hoyle CH and Burnstock G (1996) Acute paw oedema formation induced by ATP: Re-evaluation of the mechanisms involved. Inflamm Res 45:96-102.